Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Net Change in Cash
Dexcom Inc
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Net Change in Cash
$228.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
24%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Change in Cash
$490m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Change in Cash
$1.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Change in Cash
$659m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Net Change in Cash
-$2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-2%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Change in Cash
$701.3m
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
See Also
What is Dexcom Inc's Net Change in Cash?
Net Change in Cash
228.1m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Net Change in Cash amounts to 228.1m USD.
What is Dexcom Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
24%
The average annual Net Change in Cash growth rates for Dexcom Inc have been 15% over the past three years , -23% over the past five years , and 24% over the past ten years .